Insulin glargine and lixisenatide Subcutaneous and Ryna-12 S
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Ryna-12 S and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: phenylephrine / pyrilamine
Brand name: K-Tan, Ryna-12
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Rynatan
- Insulin glargine and lixisenatide Subcutaneous-Rynatan Chewable Pediatric Tablets
- Insulin glargine and lixisenatide Subcutaneous-Rynatan Pediatric Suspension
- Insulin glargine and lixisenatide Subcutaneous-Rynatuss Tablets
- Insulin glargine and lixisenatide Subcutaneous-Rynex DM
- Insulin glargine and lixisenatide Subcutaneous-Rynex PE
- Ryna-12 S-Insulin glargine, recombinant Subcutaneous
- Ryna-12 S-Insulin glulisine
- Ryna-12 S-Insulin Glulisine (Cartridges and Pens)
- Ryna-12 S-Insulin Glulisine (Vials)
- Ryna-12 S-Insulin glulisine Subcutaneous
- Ryna-12 S-Insulin human inhaled Inhalation